Medical Newswire

Medical Newswire!

Medicine, Healthcare, Medical Research, Hospitals, Management
Press release distribution service
Home | Medical-Newswire.Com:

Sunitinib Malate Market worth $ 76.7 Million by 2021

 



(Medical-NewsWire.com, April 20, 2019 ) The report "Sunitinib Malate Market Forecast for Pancreatic Cancer, 2016-2017, G7 Countries, (U.S., Germany, France, U.K., Italy, Spain, Japan)", The sunitinib malate market for pancreatic cancer is projected to reach USD 76.7 Million by 2021, at a CAGR of 13.9% from 2016 to 2021.



Browse 14 market data Tables spread through 26 Pages and in-depth TOC on "Sunitinib Malate Market Forecast for Pancreatic Cancer, 2016-2017, G7 Countries, (U.S., Germany, France, U.K., Italy, Spain, Japan)"



http://www.marketsandmarkets.com/Market-Reports/sunitinib-malate-market-194614514.html



Early buyers will receive 10% customization on reports.

Download Free PDF Brochure:- http://www.marketsandmarkets.com/pdfdownload.asp?id=194614514



A number of factors, such as increasing incidence of pancreatic cancer, availability of a limited number of drug therapeutic options for the treatment of advanced pancreatic neuroendocrine tumors, and poor diagnosis rate in the early stages of pancreatic cancer are driving the demand of sunitinib malate in the treatment of pancreatic cancer. Also, the overall number of patients who are eligible for taking sunitinib malate is expected to grow at a high CAGR during the forecast period.



In this report, the market is segmented into seven country-level segments, namely, the U.S., Germany, France, the U.K., Italy, Spain, and Japan. The U.S. is expected to dominate this market primarily due to the higher number of patients suffering from pancreatic cancer in the country. However, the market in the U.K. is expected to witness the highest growth rate during the forecast period.



For Further Inquiry: - http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=194614514



This report contains detailed analysis of the sunitinib malate market for pancreatic cancer in terms of epidemiology, number of drug-treated patients suffering from pancreatic neuroendocrine tumors (pNET), percentage of patients eligible for taking sunitinib malate, penetration of sunitinib malate in pNET patients, number of pancreatic cancer patients, incidence rate of pancreatic cancer, 5-year survival rate of pNET patients, penetration of drug therapy in pancreatic cancer treatment, and trends in the adoption of sunitinib malate. This report also includes pricing analysis of sunitinib malate in all G7 countries and year-on-year market size of sunitinib malate for pancreatic cancer from 2010 to 2021.



MarketsandMarkets™

Mr. Shelly Singh

1-888-600-6441

raviraj.tak@marketsandmarkets.com

Source: EmailWire.Com

Source: EmailWire.com


Medical Resources
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Healthcare resource center today to browse our selection of 600+ complimentary Healthcare magazines, white papers, webinars, podcasts, and more. Get popular titles including:

Eyecare Business
Medical Laboratory Observer
FierceHealthcare

No credit cards, coupons, or promo codes required. Try it today!

Medical Sponsors

Health News


Pharmanewswire.com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © GroupWeb Media LLC. All Rights Reserved.

For unlimited press release distribution for $99 per month, call (281) 645-4086 or start posting your press releases online at EmailWire.com. CityRegions.Com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © 2012 GroupWeb Media LLC. All Rights Reserved.


GroupWeb Media Network
AfricaNewswire.Net | AppleNews247.Com | AsiaNewsWire.Net | Aviation-NewsWire | Energy Industry | EstateNewsWire | Entertainment-NewsWire.com | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | EuropeNewsWire.Net | iCameroon.com | i-Canada-News.Com | i-SoftwareNews.com | iT-NewsWire.Com
| InvestorsNewsDesk.Com | i-TravelNewsWire.Com | LegalLaw247.com | Medical-NewsWire.com | MiningNewsWire.net | MoneyNewsWire.Net | Movie-Stars-News.Com | PayDayNews247.Com | PharmaNewsWire.Com | Publishing-NewsWire.Com | Shopping-NewsWire.com | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com |
Medical-Newswire.com - Medicl Newswire and Press Release service of GroupWeb Media LLC